These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25446103)

  • 1. miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1.
    Wan LY; Deng J; Xiang XJ; Zhang L; Yu F; Chen J; Sun Z; Feng M; Xiong JP
    Biochem Biophys Res Commun; 2015 Feb; 457(2):125-32. PubMed ID: 25446103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro.
    Deng J; Lei W; Fu JC; Zhang L; Li JH; Xiong JP
    Biochem Biophys Res Commun; 2014 Jan; 443(3):789-95. PubMed ID: 24275137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
    Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
    Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
    Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
    Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.
    Duan N; Hu X; Yang X; Cheng H; Zhang W
    Int J Clin Exp Pathol; 2015; 8(9):10250-60. PubMed ID: 26617733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
    Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
    Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer.
    Li XR; Chu HJ; Lv T; Wang L; Kong SF; Dai SZ
    FEBS Lett; 2014 Aug; 588(17):3298-307. PubMed ID: 25066298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.
    Zeng M; Zhu L; Li L; Kang C
    Cell Mol Biol Lett; 2017; 22():12. PubMed ID: 28725241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
    Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
    Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer.
    Inoguchi S; Seki N; Chiyomaru T; Ishihara T; Matsushita R; Mataki H; Itesako T; Tatarano S; Yoshino H; Goto Y; Nishikawa R; Nakagawa M; Enokida H
    FEBS Lett; 2014 Aug; 588(17):3170-9. PubMed ID: 24999187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
    He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J
    Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of microRNA-1 and microRNA-145 contributes synergistically to the development of colon cancer.
    Xu X; Wu X; Jiang Q; Sun Y; Liu H; Chen R; Wu S
    Int J Mol Med; 2015 Dec; 36(6):1630-8. PubMed ID: 26459459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.
    Sun Y; Yu X; Bai Q
    Int J Clin Exp Pathol; 2015; 8(10):12775-83. PubMed ID: 26722467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-137 chemosensitizes colon cancer cells to the chemotherapeutic drug oxaliplatin (OXA) by targeting YBX1.
    Guo Y; Pang Y; Gao X; Zhao M; Zhang X; Zhang H; Xuan B; Wang Y
    Cancer Biomark; 2017; 18(1):1-9. PubMed ID: 28035913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
    Li J; Wang Y; Luo J; Fu Z; Ying J; Yu Y; Yu W
    FEBS Lett; 2012 Oct; 586(20):3761-5. PubMed ID: 23010597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells.
    Meerson A; Yehuda H
    BMC Cancer; 2016 Nov; 16(1):882. PubMed ID: 27842582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.
    Jin Y; Cheng H; Cao J; Shen W
    J Cell Biochem; 2019 Nov; 120(11):18629-18639. PubMed ID: 31338872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.
    Liang Y; Zhao Q; Fan L; Zhang Z; Tan B; Liu Y; Li Y
    Biomed Pharmacother; 2015 Oct; 75():137-41. PubMed ID: 26320367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating.
    Tang Q; Zou Z; Zou C; Zhang Q; Huang R; Guan X; Li Q; Han Z; Wang D; Wei H; Gao X; Wang X
    Tumour Biol; 2015 Mar; 36(3):1701-10. PubMed ID: 25371073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.